U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07455578) titled 'Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease' on Feb. 13.
Brief Summary: This is a multi-center, open-label Ph 1b basket study to assess safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, biomarker response, and preliminary efficacy of S-4321 in adults with autoimmune or immune-mediated disease including rheumatoid arthritis (RA), psoriatic arthritis (PsA), psoriasis (PsO), cutaneous lupus erythematosus (CLE) with or without systemic manifestations, or atopic dermatitis (AD).
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Autoimmune Diseases
Rh...